A therosclerosis and its major sequela, cardiovascular disease, are major causes of mortality and morbidity in the United States.
A therosclerosis and its major sequela, cardiovascular disease, are major causes of mortality and morbidity in the United States. 1 Atherosclerosis, which is characterized by the accumulation of cholesterol in macrophages within the subendothelial space of the arterial wall, is suppressed by reverse cholesterol transport (RCT). [2] [3] [4] According to one model, [3] [4] [5] RCT is a 3-step process whereby arterial macrophage-cholesterol transfers to the liver for disposal. The initial RCT step is the formation of nascent high-density lipoproteins (nHDL) via the interaction of apolipoprotein (apo) AI with the ABCA1 lipid transporter; the nHDL so formed contains mainly apo AI, free cholesterol (FC), and phospholipid (PL). 6, 7 The second step has both molecular and macromolecular consequences, respectively, esterification of nHDL-FC to cholesteryl ester (CE) by plasma lecithin:cholesterol acyltransferase (LCAT) and concurrent conversion of nHDL from a disc to a sphere with a central CE core. In the third step-cholesterol disposal-hepatic SR-B1 (scavenger receptor class B member 1) selectively extracts lipids from HDL via a nibbling mechanism in which apo AI and apo AII are excluded from uptake and HDL is reduced to a remnant while releasing lipid-free apo AI. 8 Although cited to near-consensus, 4 this RCT model has never been rigorously validated. Herein we provide data showing that the major components of ABCA1-derived HDL-FC, PL, and apo AI-segregate in serum in vitro and enter different pathways for clearance in vivo. Importantly, our results reveal that a major portion of the rapid hepatic nHDL-FC and PL clearance is independent of the reaction catalyzed by LCAT. These data are important in the context of the current segue from HDL-C is the good cholesterol to HDL functionality is at least equally important. 4, [9] [10] [11] [12] [13] 
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Size Exclusion Chromatography Analysis of nHDL
nHDL was produced by incubation of apo AI with ABCA1-expressing bovine hamster kidney (BHK) cells with and without methyl β-cyclodextrin (CDX)-mediated FC loading. The media from each incubation were collected, concentrated, and analyzed. After the cells were FC-loaded with 0, 0.06, and 0.26 mmol/L FC (0, 2.5, and 5 mmol/L CDX, respectively), the resulting cellular FC contents were 29±2, 42±6, and 52±6 μg/mg cell protein. The size exclusion chromatography (SEC) profiles of the media ( Figure 1 ) revealed 2 well-resolved peaks for protein absorbance corresponding to medium and small nHDL, nHDL-M and nHDL-S, respectively, which were collected and analyzed by SEC ( Figure 1A through 1C, chromatograms b and c). Based on past in vitro and in vivo studies 6, 14 showing a large nHDL is formed from FC-loaded cells, we collected a third larger (L), less prominent, and earlier-eluting nHDL-L ( Figure 1A through 1C, chromatogram a). SEC analysis of the pooled fractions for nHDL-L, -M, and -S showed that in the absence of CDX-mediated FC loading, only 2 nHDL were formed ( Figure 1A , chromatograms b and c). However, the SEC profile of nHDL from CDX-mediated FC-loaded cells revealed 3 fractions ( Figure 1B and 1C, chromatograms a-c) . The first 2, nHDL-M and S, were similar to those found without CDXmediated FC loading; the third, larger nHDL-L, was unique to nHDL formed from CDX/FC-loaded cells. Based on SEC and comparison with the elution volumes of standard proteins, the respective diameters of nHDL-L, M, and S were 14.5, 12.2, and 8.8 nm; the corresponding molecular weights were 510, 262, and 96 kDa. According to nondenaturing PAGE ( Figure 1D ), the molecular weights were 482, 298, and 91 kDa respectively. Of note, while not detected by SEC, a minor amount of nHDL-L, detected by nondenaturing PAGE, was formed in cells without FC loading (Lane L, No CDX). As expected and shown in the SDS-PAGE ( Figure 1E ), apo AI is the dominant protein in all 3 nHDL fractions, but minor bands in the 60 to 200 kDa range are also detected. The remainder of our studies was performed with the most abundant fraction, nHDL-M, which for brevity will from hereon be called nHDL. nHDL used in our study is, according to SEC, stable; repeat analytic SEC runs 1 and 3 months apart were identical.
nHDL Composition
The trends in nHDL composition as a function of particle size were similar for all 3 FC loading conditions. PL/apo AI, FC/ apo AI, and FC/PL molar ratios and mol% FC in each particle increased with nHDL particle size ( (Figure 3 ; peak elution volume 16 mL); the former had a transfer halftime =≈6.5 minutes and reached ≈33% of total disintegrations per minute at t≥30 minutes ( Figure 3C ). In whole serum, the halftime for nHDL-[
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14 C]PL transfer to HDL appeared to be on a time scale similar to that for transfer to LDL but could not be quantified because the elution volumes of nHDL-[ Figure IX in the online-only Data Supplement. Figure 5 compares the distribution of nHDL-FC, PL, and apo AI at the end of 2-and 24-hour incubations with serum (from the data of Figures 2-4) . These data show that each component of nHDL has a different fate. After a 2-hour incubation, nHDL-FC distributes as LDL>HDL>>very low-density lipoprotein; nHDL-PL distributes as HDL>LDL>lipid-poor apo AI>very low-density lipoprotein; nHDL-apo AI distributes as HDL>lipid-poor apo AI>>LDL. The distribution of nHDL analytes is only slightly different after a 24-hour incubation with serum.
Serum Factors Segregate nHDL-FC, PL, and Apo AI
In Vivo nHDL Metabolism
The plasma clearance of the constituents of nHDL and their appearance in major organs was followed in groups of mice after injection of nHDL- Figure 6C ). These data best fit a biexponential curve having fast and slow components with halftimes of 2.1±1.0 minutes and 7.7±1.3 hours; the respective pre-exponential factors, which reflect the relative contributions of the 2 components to the total decay, were 0.68 and 1.9, that is, 25% and 75% of the total. In the same experiment, we collected tissues at various times and determined their associated [ Table 2 .
PLTP Increases Hepatocyte nHDL-PL Uptake
Given the rapid removal of nHDL-[ FC uptake, which were not affected by addition of PLTP to the incubation media ( Figure 7A and 7C) Figure 7B and 7D) . When uptake was calculated as percent of input, FC uptake from both nHDL and HDL was 30% at 180 minutes, while PL uptake, in this case PC uptake, in the absence of PLTP was 5% and increased to 10% from nHDL in the presence of PLTP. Greater uptake of FC versus PC has also been reported for fibroblasts.
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Discussion
Formulation of the RCT Hypothesis
Discovery of the role of LCAT in HDL metabolism provoked the hypothesis that cholesterol esterification is part of a broader cholesterol transport process that prevents accumulation of cytotoxic FC levels in peripheral tissue. [21] [22] [23] This process, now known as RCT, was hypothesized decades before the transporters involved in the first step, nHDL production mainly by ABCA1, 24, 25 and the selective hepatic lipid-uptake receptor, SR-B1, 26 involved in the final disposal step, were identified. In the context of atheroprotection by HDL, RCT evolved into a 3-step process-cholesterol efflux from ABCA1-expressing macrophages in the subendothelial space of the arterial wall to apo AI or pre-β HDL giving rise to nHDL, esterification of nHDL-FC by plasma LCAT producing more mature, spherical HDL, and selective hepatic extraction of HDL-CE by SR-B1, which nibbles a few CE from many HDL. 8 In the liver, CE is converted to FC, some of which is converted to bile salts, both of which enter the bile and then transfer to the feces for excretion. 27 nHDL Composition, Size, and Structure ABCA1-derived nHDL is thought to be a precursor to the mature forms of HDL that occur in plasma. The composition, size, and structure of ABCA1-derived nHDL, 6, 7 as well as the metabolism of nHDL protein derived from several cell types, including macrophage foam cells, have been reported and are similar. 18, 28, 29 Cell-ABCA1-derived nHDL is both similar and different from human plasma pre-β HDL. Both contain FC, PL, and apo AI. However, the human plasma pre-β HDL is smaller and is ≈90% protein, mostly apo AI, 30 and has been proposed to be a terminal nascent HDL product, 18 a conclusion that is consistent with the likely rapid removal of lipids from nascent HDL soon after its production as reported here and by others. 19, 31 This difference may limit the transferability of findings with ABCA1-derived nHDL to human pre-β HDL metabolism.
nHDL-lipid metabolism has not been reported so that we have advanced the state of knowledge of the role of nHDL analytes in HDL metabolism and are the first to study the plasma clearance and tissue uptake of nHDL-FC, PL, and apo AI derived from the same cell system and using the same mouse model, C57BL/6J mice. The major novelty of our contribution is the observed rapid, quantitative in vivo metabolism of the nHDL-FC and PL in a background of slower apo AI metabolism in which LCAT plays a minor role in the nHDL-FC clearance and tissue uptake. These findings should guide the design of therapies that promote the transfer of peripheral tissue FC to the liver for disposal. (Table 1) has been reported previously for large and medium nHDL formed by BHK-ABCA1 cells, 6, 32 as well as HEK293 (human embryonic kidney)-ABCA1 cells. 7 Our data confirm that nHDL-sphingomyelin content increases with increasing nHDL size 35 and that erythrocytes are FC and PL reservoirs (Figures VI and VII in the online-only Data Supplement). 36 Most variously sized nHDL are discoidal, 37 and according to electron microscopy studies, both 9 and 12 nm diameter nHDL from J774 macrophage cells are discoidal. 34 Our preliminary electron cryo-microscopic studies of nHDL from BHK-ABCA1 cells also show a discoidal structure (J. Michael Bell et al, unpublished). In contrast, nHDL from HEK293-ABCA1 cells were reportedly mostly spherical. 7 We confirmed 6, 7 that the nHDL from BHK-ABCA1 cells is FC rich and contains PL and apo AI and then studied the in vitro and in vivo fates of [ 
In Vitro Fates of nHDL-FC, PL, and Apo AI
The rate-limiting step for spontaneous lipid transfer from particle surfaces is desorption, 38, 39 which follows Kelvin's law stating that desorption halftimes are a positive function of particle radius. 40, 41 Differences in particle shape-HDL is a sphere and nHDL is a disc-and composition-nHDL and HDL are 60 (Table 1 ) and 10 mol% FC 42 -play unknown roles. However, with these caveats, we conclude that their similar Stokes radii would dictate similar halftime for FC desorption from nHDL and HDL, that is, ≈2 to 4 minutes. 15 Consistent with this, the halftimes for nHDL-[ Figure 2E ). Given that FC desorption rates are independent of the identity of the acceptor, 15 the rate of nHDL-[
transfer to HDL is the same as its transfer to LDL, ≈2 to 4 minutes. In whole serum, the number of HDL particles is 10× that of all other lipoprotein particles combined 43 so that based on collision theory, the first encounter of desorbing nHDL-[ 3 H] FC is expected to be HDL, the same as that found for plasma acceptors of macrophage FC efflux. 44 
nHDL-and HDL-[
The in vitro transfer halftime of dipalmitoylphosphatidylcholine from HDL 3 to LDL is longer than that of FC, that is, 5 hours, 15 which is similar to what we observed for nHDL-PL transfer to TLPs (3.4 hours), LDL (4.1 hour), and HDL (2.1 hour; Figures III-V in the online-only Data Supplement). In contrast, nHDL-[ 14 C]PL transfer to lipoproteins in whole serum is faster (t 1/2 =6.5 minutes; Figure 3C ). We attribute the faster rate of PL transfer in whole serum to PLTP activity 45 for several reasons as discussed below. nHDL-apo AI transfers to HDL within 10 minutes in vitro (Figure 4) , and between 2 and 24 hours, some HDL-associated apo AI transfers to the lipid-free or lipid-poor form, an effect that is likely a function of HDL instability; 46, 47 HDL is disrupted by many HDLmodifying factors-LCAT, CE, and PL transfer proteins and endothelial and hepatic lipases. [48] [49] [50] [51] [52] The distribution of nHDL-[ (Figure 5 ), which is near equilibrium, is similar to the natural distribution of FC, PL, and apo AI among serum lipoproteins. 42, 53 Most FC is in LDL, while more PL is in HDL than LDL, and nearly all apo AI is in HDL. 
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Metabolic Fates of nHDL-FC, PL, and Apo AI In Vivo
The disappearance halftime for plasma nHDL-[ 3 H]FC in vivo (t 1/2 =5.2 minutes; Figure 6A ) is comparable to its in vitro transfer to plasma lipoproteins, primarily HDL (t 1/2 =2.1 minute; Figure 2E ); the longer t 1/2 observed by SEC ( Figure 2D) 57 and compared with WT mice, hepatic removal of HDL-FC is faster in mice overexpressing SR-B1. 19 Given the size and compositional similarities of nHDL and HDL, we propose that some nHDL-[
3 H]FC is also cleared by hepatic SR-B1. The rates of desorption of both nHDL-and HDL-FC are rapid so that direct receptor-independent, spontaneous transfer to the plasma membranes of liver cells is a likely second mechanism underlying the accretion of [ (Figure 3) . Thus, transfer of nHDL-[ 14 C]PL from plasma to liver must involve a plasma factor or a hepatic receptor. This factor is likely PLTP, a conclusion supported by 4 observations: nHDL is a PLTP target 18, 28 ; injection of PLTP into rat doubles the rate of clearance of an rHDL-PC ether 59 ; transfer of nHDL-[ 19,57 also be cleared by hepatic SR-B1, although the much slower rate of selective uptake compared with FC (12%) 60 could make this mechanism quantitatively less important. Hydrolysis could also play a role but only at much longer times. For example, in rat, the plasma t 1/2 for the disappearance of [ 3 H]PC is ≈1 hour. This process is mediated, in part, by LCAT and hepatic lipase-mediated hydrolysis, which account for ≥90% of PC clearance. 61 In contrast to the nHDL lipids, the plasma t 1/2 for nHDL-[
125 I]apo AI is longer, 460 minutes, and after fusion with HDL and its subsequent release as lipidfree or poor, apo AI is available for additional efflux cycles.
Relevance to Human Pathophysiology
It is interesting to compare our data with similar human kinetic studies of plasma HDL- apo AI interaction with cellular ABCA1 forms nHDL containing FC, PL, and apo AI. nHDL-FC rapidly transfers to the liver either directly or via initial transfer to HDL, followed by transfer to the liver; this occurs via both SR-B1 and spontaneous transfer. nHDL-PL transfer to liver occurs directly or via HDL, and although our cell data implicate PLTP in this process, it is not clear whether PLTP is a direct mediator or that PLTP simply modifies nHDL in a way that accelerates PL uptake; the latter hypothesis is supported by the observation that PLTP is essential to nHDL remodeling. 18 Ultimately, FC and PL equilibrate among all lipoproteins giving steady-state plasma concentrations that are the targets of enzymes and transfer proteins. Although our model also shows hepatic LDL-lipid uptake via the LDLR (LDL receptor), this process is not as important during the early rapid hepatic uptake but contributes to hepatic removal at longer times when lipoprotein concentrations have equilibrated to a stationary state. Notably, these fast lipid transfer processes are independent of LCAT activity, which acts on a slower time scale. Over longer time intervals, erythrocytes accrue ≈10% of nHDL-FC and PL deposition.
In vitro, nHDL-apo AI associates with HDL, with some appearing lipid-free at longer incubation times with serum. In vivo, nHDL-apo AI also transfers to HDL where it remains with a halftime of 460 minutes ( Figure 6C ). No lipid-free apo AI was detected in vivo, suggesting that soon after plasma factors convert nHDL-apo AI to the lipid-free form, it immediately reassociates with HDL or initiates another cycle of tissue cholesterol efflux. Clearly, nHDL structure is disrupted by plasma factors in vitro and in vivo its components-FC, PL, and apo AI-are cleared by independent mechanisms that do not involve holo-particle uptake. nHDL-apo AI persists in plasma longer than nHDL-FC and PL, which rapidly move through the plasma compartment while maintaining a stationary state of HDL-FC, PL, and apo AI. Given the similarities between HDL and nHDL metabolism, we conclude by paraphrasing from Schwartz et al 63 who studied human HDL-FC metabolism, that is, "nHDL-FC and PL constantly exchange between HDL and tissue membranes, while maintaining a steady state HDL composition." Figure 8 . Model of nascent high-density lipoprotein (nHDL) remodeling and metabolism in vivo. Cells extrude free cholesterol (FC) and phospholipid (PL) via the interaction of apolipoprotein (apo) AI with ABCA1 giving nHDL (1). nHDL-FC, PL, and apo AI rapidly transfer to HDL, t 1/2 <2 minutes (2); concurrently nHDL-FC and PL transfer to low-density lipoprotein (LDL; 3). Over the same time frame, nHDL-and HDL-FC and PL transfer mainly to the liver (4-6) while some nHDL-apo AI is recycled to ABCA1 (7). Over time, FC and PL equilibrate among erythrocytes (8), extrahepatic tissues, and lipoproteins, which achieve a steady state concentration that is the target of enzymes, transfer proteins, and hepatic receptors. nHDL-and HDL-FC and PL accretion in the liver occurs via spontaneous transfer and SR-B1 (scavenger receptor class B member 1; 4-6), with the latter being promoted by phospholipid transfer protein (PLTP; 4). Symbols for FC, PL, and apo AI are labeled as shown in the legend at the top of the figure.
